• / Free eNewsletters & Magazine
  • / My Account

CROs

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: Pharmacovigilance and Drug Safety Software Market by Functionality, Delivery Mode, End-User - Global Forecasts to 2019

    Research and Markets: Pharmacovigilance and Drug Safety Software Market by Functionality, Delivery Mode, End-User - Global Forecasts to 2019

  2. PAREXEL Wins IABC 2015 Gold Quill Merit Award for Digital Communications

    PAREXEL Wins IABC 2015 Gold Quill Merit Award for Digital Communications

  3. Medidata Expands Partnership with Peking University to Increase Access to Cloud-Based Technology for Clinical Trials Across China

    Medidata Expands Partnership with Peking University to Increase Access to Cloud-Based Technology for Clinical Trials Across China

  4. Accenture Life Sciences Expands Its Cloud Capabilities for R&D with Advanced Clinical Trial Automation Services

    Accenture Life Sciences Expands Its Cloud Capabilities for R&D with Advanced Clinical Trial Automation Services

  5. Late-Stage Businesses Drive Narrow Moats for CROs

    The top contract research organizations have opportunities to gain share in a rapidly growing industry.

  6. Cipher Pharmaceuticals acquires Canadian rights to novel treatment for psoriasis and rheumatoid arthritis

    Cipher Pharmaceuticals acquires Canadian rights to novel treatment for psoriasis and rheumatoid arthritis

  7. CORRECTING and REPLACING Five of the World’s Top 20 Pharmaceutical Companies Standardize on Veeva Vault eTMF to Manage Clinical Trial Documents Globally

    CORRECTING and REPLACING Five of the World’s Top 20 Pharmaceutical Companies Standardize on Veeva Vault eTMF to Manage Clinical Trial Documents Globally

  8. Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA® (ivermectin) Cream 10mg/g for Rosacea Patients

    Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA® (ivermectin) Cream 10mg/g for Rosacea Patients

  9. Health Care’s Outlook Clarifies

    Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.

  10. Amid Turmoil, Don’t Discount Foreign Equities

    Use this screen to find overlooked small- and mid-cap international stocks.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.